medication
Seizing the MTM Opportunity:
What Psychiatric Pharmacists Need to Know
This presentation will focus on how the health care system is changing and how psychiatric pharmacists need to adapt to these changes to be successful. The objectives for the presentation will be to; a) understand the changing environment, b) adopt terminology that has currency in the new system, c) understand the new rules and regulations, d) be able to recognize success under the new rules, and e) decide which direction for the future is best. The specific changes that impact psychiatric pharmacists will be presented and the consequences of these changes discussed. Read more about this session.
2010-2011 Psychiatric Pharmacy Review Course - ACPE Credit Only
The Psychiatric Pharmacy Review Course (Review Course) is an excellent course of study and resource for those seeking a review of psychopharmacology and current standards of care. Read more about this session.
Satisfaction With Methadone as a Medication: Psychometric Properties of the Spanish Version of the Treatment Satisfaction Questionnaire for Medication
Abstract: There is a manifest lack of psychometrically sound instruments designed for specific and multidimensional assessment of satisfaction with methadone as a medication within the context of methadone maintenance treatment.
All-Cause Mortality and Medication Risk Factors in Schizophrenia: A Prospective Cohort Study
Background: It is well established that persons with schizophrenia have high mortality rates. There is conflicting evidence that antipsychotic and perhaps other medications routinely used to treat schizophrenia contribute to mortality risk.
Methods: A health insurer database was used to examine schizophrenia diagnosis and mortality in 2008. Information from the period 2006–2008 was used to analyze demographics and medication prescriptions.
Does the Medication Pattern Reflect the CYP2D6 Genotype in Patients With Diagnoses Within the Schizophrenic Spectrum?
Background: Cytochrome P450 2D6 enzyme (CYP2D6) is an important metabolic pathway for many antipsychotics.
Can people with nonsevere major depression benefit from antidepressant medication?
Stewart JA, Deliyannides DA, Hellerstein DJ, et al. | | |
Statin Use and Risk of Diabetes Mellitus in Postmenopausal Women in the Women's Health Initiative [Original Investigation]
Background This study investigates whether the incidence of new-onset diabetes mellitus (DM) is associated with statin use among postmenopausal women participating in the Women's Health Initiative (WHI).
CPNP’s 2011 Annual Meeting keynote speaker Linda Strand, PharmD, PhD, provided a motivating, can-do view of healthcare reform legislation and the opportunities available to pharmacists.